Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Lipocine Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 19 | +1 |
| Shares | 473.9K | 531.6K | +57.7K (+12.2%) |
| Value | $2.46M | $4.38M | +$1.92M (+77.7%) |
New holders (4)
Institutions that held Lipocine Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 13,160 | $108.4K | 0.00% |
| Dimensional Fund Advisors LP | 11,870 | $97.8K | 0.00% |
| Clearstead Advisors, LLC | 74 | $610 | 0.00% |
| Bank of America Corp | 44 | $363 | 0.00% |
Sold out (3)
Institutions that held Lipocine Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Old Point Trust & Financial Services N A | 59 | $307 |
| Wells Fargo & Company | 42 | $218 |
| JPMorgan Chase & Co | 12 | $62 |